OTC Stock Picks Presents Awesome Penny Stocks to Watch - ATTD, GNBT, SWVI, FOYJ

Stamford, CT -- (SBWIRE) -- 02/01/2013 -- OTC Stock Picks is engaged in providing the most up to date and useful information on the Best Penny Stocks poised to breakout. Our newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. These are the awesome penny stocks that the ‘underground penny stock experts’ brag about in our penny stock blogs.
Attitude Drinks Inc (NDA) (OTC:ATTD) closing price was $0.0003 during the last trading session. The company traded with the total volume of 81.01 million shares, while its average trading volume remained 174.30 million shares. The beta of ATTD stands at 1.39.
Have a look at the company’s graph:
During the last one month, it rose 50%. Its year to date performance remained progressive 50%.The 52-week high price of the stock remained $0.01.

How Should Investors Trade ATTD Now? Don’t Miss out a Special Trend Analysis

Generex Biotechnology Corporation (OTC:GNBT) percentage change reduced -29.47%, to close at $0.0450 with the total traded volume of 49.69 million shares, more than average volume of 5.69 million.
The Company’s year to date performance remained optimistic with the rise of 80%. If we look at its last 6 months of trade, that is in the bearish zone with a drop of -51.61%
Its beta value stands at 1.60 times and earnings per share was -$0.03. The company has a total of 372.06 million outstanding shares and its total market capitalization is $16.74 million.
The 52-week price range of the stock remained $0.02 - $0.19, while during last trade its minimum price was $0.04 and it gained its highest price of $0.07.
Generex Biotechnology explained the potential of the technology platform used as the basis for its novel breast cancer immunotherapy product AE37. AE37 is currently in late Phase IIb clinical development and has garnered considerable attention based upon favourable results from interim analysis of its controlled, randomized, and blinded trial in women with early stage breast cancer.

Has GNBT Found The Bottom and Ready To Move Up? Find Out Here

SWINGPLANE VENTURES (OTC: SWVI) started its trading session with the price $0.36 and closed at $0.379 by scoring 4.99%. Day trading range of SWVI was $0.29 -$0.38.
A review of its graph:
Previous 5 days graph demonstrated a positive move of 26.33%. SWVI’s quarterly performance remained in the green 152.67%, while its year to date performance showed that the stock advanced overall 64.78%.
SWVI’s stocks traded with total volume of 20.32 million shares, while the average trading capacity remained 5.21 million shares.

Will SWVI Continue To Move Higher? Find Out Here

FOY JOHNSTON INC (PINK:FOYJ) currently has a market capitalization of $172.38million. The stock’s closing price was $0.0014.

Graph values of the stock demonstrate these trends: Year to date performance of the stock remained positive with the rise of 180%. FOYJ traded with volume of 152.38 million shares, while its average trading ability remained 3.53 million shares.

Where is FOYJ Headed Exactly? Find out in This Trend Analysis Reports

About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.

Disclaimer
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company websites, but this should not be construed as a recommendation to buy or sell.